Theoretical assessment of Au32 nanocluster as tiopronin drug agent: DFT calculation and MD simulation; with solvent
Hadil Faris Alotaibi1, Anjan Kumar2, Yashwantsinh Jadeja3
1Department of Pharmaceutical Sciences, College of Pharmacy, Princess Nourah Bint AbdulRahman University, Riyadh, 11671, Saudi Arabia.
Abstract:
In recent years, significant attention has been directed toward the application of AuNPs due to their favorable interactions with biological systems and their comparatively low cytotoxicity relative to other metal-based platforms. In this research, we utilize DFT to investigate the interaction between a model Au32NC and tiopronin in both gas and aqueous phases. We present a comprehensive analysis of the structural properties, adsorption energies, and electronic characteristics of the resulting complexes, providing atomic-scale insights into the potential of Au32NCs as nanocarriers drugs. For the Au32NCs, the Lanl2DZ basis set was utilized, while the 6-31++G(d,p) basis set was applied to the tiopronin molecule. The most notable negative adsorption energies are recorded for Au32@ tiopronin, with values of -12.57, -10.38, and -11.16 kcal mol-1 in the gas phase, and -11.54, -7.04, and -3.57 kcal mol-1 in the aqueous environment, respectively. Moreover, AIMD simulations validate the thermal stability of the nanohybrid at 300K, with recovery time identified as a critical factor in drug delivery. The findings indicate that Au32@tiopronin, as a carrier, possesses favorable characteristics from both energetic and structural perspectives, positioning it as a promising candidate for targeted drug delivery applications. This computational study offers valuable insights into the design and development of Au32 nanocarriers for therapeutic agents aimed at assisting rheumatoid arthritis patients in minimizing side effects and enhancing the efficacy of the tiopronin drug.
More Related Videos
12:11Computation of Atmospheric Concentrations of Molecular Clusters from ab initio Thermochemistry
Published on: April 8, 2020
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
